1GallaJ H. IgAnephropathy[J].Kidney Int,1995,47(2):377-387.
2Julian B A. Treatment of IgA nephropathy[J ]. Semin Nephrol, 2000,20: 277 - 285.
3Berthoux F C, Alamartine E, Pom mier G, et al. HLA and IgA nephritis revisited 10 years later: HLA- B35 antigen as a prognostic factor[J]. N Engl J Med, 1988,319:1609 - 1610.
4Hunley T E, Julian B A. Phillips Ⅲ J A, et al. Angiotensin converting enzyme gene polymorphism: Potential silence motify and impact on progression in IgA nephropathy[J ]. Kidney Int, 1996,49:571 - 577.
5LocateUi F,Vecchio LD,Pozzoni P. The importance of early detection of chronic kidney disease[J]. Nephrol Dial Transplant, 2002, 17(11) :2-7.
6Petkov J, Harvey P, Battersby MW. The internal consist- ency and construct validity of the partners in health scale : Validation of a patient rated chronic condition selffnana- gement measure. Quality of Life Research, 2010,19: 1079-1085.
7Battersby MW, Ask A,Reece MM, et al. The partners in health scale :The development and psychometric properties of a generic assessment scale for chronic condition self- management[J]. Australian Journal of Primary Health,2003, 9(3) :41-53.
